Parliamentary QA
Extension of Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination under National Vaccination Programme to Delayed Serious Side Effect Cases
12 January 2022
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NOTICE PAPER NO. 879
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON 12 JANUARY 2022
Name and Constituency of Member of Parliament
Mr Zhulkarnain Abdul Rahim
MP for Choa Chu Kang GRC
Question No. 1386
To ask the Minister for Health whether the Vaccine Injury Financial Assistance Programme for COVID-19 vaccination under the National Vaccination Programme can be extended to cases where the serious side effects only appear after a considerable period of time after vaccination, provided there is clear expert corroboration of the correlation between the serious side effects and the vaccine received.
Answer
Serious side effects caused by vaccines are rare. This applies for COVID-19 vaccines or vaccines protecting against other conditions. Most side-effects are mild, appear within the first three days and resolve with no treatment. Rarely, side effects can develop up to six weeks after vaccination.
2 Applications for the Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination (VIFAP), will be considered thoroughly, taking into account the details of the medical episode that occurred post-vaccination, together with scientific information and evidence.